Literature DB >> 14505273

Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract.

Christina L Liquori1, Yoshio Ikeda, Marcy Weatherspoon, Kenneth Ricker, Benedikt G H Schoser, Joline C Dalton, John W Day, Laura P W Ranum.   

Abstract

Myotonic dystrophy (DM), the most common form of muscular dystrophy in adults, can be caused by a mutation on either chromosome 19 (DM1) or 3 (DM2). In 2001, we demonstrated that DM2 is caused by a CCTG expansion in intron 1 of the zinc finger protein 9 (ZNF9) gene. To investigate the ancestral origins of the DM2 expansion, we compared haplotypes for 71 families with genetically confirmed DM2, using 19 short tandem repeat markers that we developed that flank the repeat tract. All of the families are white, with the majority of Northern European/German descent and a single family from Afghanistan. Several conserved haplotypes spanning >700 kb appear to converge into a single haplotype near the repeat tract. The common interval that is shared by all families with DM2 immediately flanks the repeat, extending up to 216 kb telomeric and 119 kb centromeric of the CCTG expansion. The DM2 repeat tract contains the complex repeat motif (TG)(n)(TCTG)(n)(CCTG)(n). The CCTG portion of the repeat tract is interrupted on normal alleles, but, as in other expansion disorders, these interruptions are lost on affected alleles. We examined haplotypes of 228 control chromosomes and identified a potential premutation allele with an uninterrupted (CCTG)(20) on a haplotype that was identical to the most common affected haplotype. Our data suggest that the predominant Northern European ancestry of families with DM2 resulted from a common founder and that the loss of interruptions within the CCTG portion of the repeat tract may predispose alleles to further expansion. To gain insight into possible function of the repeat tract, we looked for evolutionary conservation. The complex repeat motif and flanking sequences within intron 1 are conserved among human, chimpanzee, gorilla, mouse, and rat, suggesting a conserved biological function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14505273      PMCID: PMC1180607          DOI: 10.1086/378720

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  26 in total

1.  The tetranucleotide UCAY directs the specific recognition of RNA by the Nova K-homology 3 domain.

Authors:  K B Jensen; K Musunuru; H A Lewis; S K Burley; R B Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome.

Authors:  Richard J Mural; Mark D Adams; Eugene W Myers; Hamilton O Smith; George L Gabor Miklos; Ron Wides; Aaron Halpern; Peter W Li; Granger G Sutton; Joe Nadeau; Steven L Salzberg; Robert A Holt; Chinnappa D Kodira; Fu Lu; Lin Chen; Zuoming Deng; Carlos C Evangelista; Weiniu Gan; Thomas J Heiman; Jiayin Li; Zhenya Li; Gennady V Merkulov; Natalia V Milshina; Ashwinikumar K Naik; Rong Qi; Bixiong Chris Shue; Aihui Wang; Jian Wang; Xin Wang; Xianghe Yan; Jane Ye; Shibu Yooseph; Qi Zhao; Liansheng Zheng; Shiaoping C Zhu; Kendra Biddick; Randall Bolanos; Arthur L Delcher; Ian M Dew; Daniel Fasulo; Michael J Flanigan; Daniel H Huson; Saul A Kravitz; Jason R Miller; Clark M Mobarry; Knut Reinert; Karin A Remington; Qing Zhang; Xiangqun H Zheng; Deborah R Nusskern; Zhongwu Lai; Yiding Lei; Wenyan Zhong; Alison Yao; Ping Guan; Rui-Ru Ji; Zhiping Gu; Zhen-Yuan Wang; Fei Zhong; Chunlin Xiao; Chia-Chien Chiang; Mark Yandell; Jennifer R Wortman; Peter G Amanatides; Suzanne L Hladun; Eric C Pratts; Jeffery E Johnson; Kristina L Dodson; Kerry J Woodford; Cheryl A Evans; Barry Gropman; Douglas B Rusch; Eli Venter; Mei Wang; Thomas J Smith; Jarrett T Houck; Donald E Tompkins; Charles Haynes; Debbie Jacob; Soo H Chin; David R Allen; Carl E Dahlke; Robert Sanders; Kelvin Li; Xiangjun Liu; Alexander A Levitsky; William H Majoros; Quan Chen; Ashley C Xia; John R Lopez; Michael T Donnelly; Matthew H Newman; Anna Glodek; Cheryl L Kraft; Marc Nodell; Feroze Ali; Hui-Jin An; Danita Baldwin-Pitts; Karen Y Beeson; Shuang Cai; Mark Carnes; Amy Carver; Parris M Caulk; Angela Center; Yen-Hui Chen; Ming-Lai Cheng; My D Coyne; Michelle Crowder; Steven Danaher; Lionel B Davenport; Raymond Desilets; Susanne M Dietz; Lisa Doup; Patrick Dullaghan; Steven Ferriera; Carl R Fosler; Harold C Gire; Andres Gluecksmann; Jeannine D Gocayne; Jonathan Gray; Brit Hart; Jason Haynes; Jeffery Hoover; Tim Howland; Chinyere Ibegwam; Mena Jalali; David Johns; Leslie Kline; Daniel S Ma; Steven MacCawley; Anand Magoon; Felecia Mann; David May; Tina C McIntosh; Somil Mehta; Linda Moy; Mee C Moy; Brian J Murphy; Sean D Murphy; Keith A Nelson; Zubeda Nuri; Kimberly A Parker; Alexandre C Prudhomme; Vinita N Puri; Hina Qureshi; John C Raley; Matthew S Reardon; Megan A Regier; Yu-Hui C Rogers; Deanna L Romblad; Jakob Schutz; John L Scott; Richard Scott; Cynthia D Sitter; Michella Smallwood; Arlan C Sprague; Erin Stewart; Renee V Strong; Ellen Suh; Karena Sylvester; Reginald Thomas; Ni Ni Tint; Christopher Tsonis; Gary Wang; George Wang; Monica S Williams; Sherita M Williams; Sandra M Windsor; Keriellen Wolfe; Mitchell M Wu; Jayshree Zaveri; Kabir Chaturvedi; Andrei E Gabrielian; Zhaoxi Ke; Jingtao Sun; Gangadharan Subramanian; J Craig Venter; Cynthia M Pfannkoch; Mary Barnstead; Lisa D Stephenson
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

3.  Segregation distortion of the CTG repeats at the myotonic dystrophy locus.

Authors:  R Chakraborty; D N Stivers; R Deka; L M Yu; M D Shriver; R E Ferrell
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

4.  Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9.

Authors:  C L Liquori; K Ricker; M L Moseley; J F Jacobsen; W Kress; S L Naylor; J W Day; L P Ranum
Journal:  Science       Date:  2001-08-03       Impact factor: 47.728

Review 5.  Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.

Authors:  Laura P W Ranum; John W Day
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

6.  Organization of the gene encoding cellular nucleic acid-binding protein.

Authors:  I L Flink; E Morkin
Journal:  Gene       Date:  1995-10-03       Impact factor: 3.688

7.  Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts.

Authors:  K Ricker; M C Koch; F Lehmann-Horn; D Pongratz; M Otto; R Heine; R T Moxley
Journal:  Neurology       Date:  1994-08       Impact factor: 9.910

8.  Myotonic dystrophy with no trinucleotide repeat expansion.

Authors:  C A Thornton; R C Griggs; R T Moxley
Journal:  Ann Neurol       Date:  1994-03       Impact factor: 10.422

9.  Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles.

Authors:  C B Kunst; S T Warren
Journal:  Cell       Date:  1994-06-17       Impact factor: 41.582

10.  High resolution genetic analysis suggests one ancestral predisposing haplotype for the origin of the myotonic dystrophy mutation.

Authors:  C E Neville; M S Mahadevan; J M Barceló; R G Korneluk
Journal:  Hum Mol Genet       Date:  1994-01       Impact factor: 6.150

View more
  26 in total

Review 1.  The Repeat Expansion Diseases: The dark side of DNA repair.

Authors:  Xiao-Nan Zhao; Karen Usdin
Journal:  DNA Repair (Amst)       Date:  2015-04-30

Review 2.  Repeat instability during DNA repair: Insights from model systems.

Authors:  Karen Usdin; Nealia C M House; Catherine H Freudenreich
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-01-22       Impact factor: 8.250

Review 3.  Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects.

Authors:  Giovanni Meola; Rosanna Cardani
Journal:  Neurol Sci       Date:  2017-01-11       Impact factor: 3.307

4.  Dutch myotonic dystrophy type 2 patients and a North-African DM2 family carry the common European founder haplotype.

Authors:  Marieke J H Coenen; Alide A Tieleman; Mascha M V A P Schijvenaars; Maike Leferink; Laura P W Ranum; Hans Scheffer; Baziel G M van Engelen
Journal:  Eur J Hum Genet       Date:  2011-01-12       Impact factor: 4.246

Review 5.  Biomolecular diagnosis of myotonic dystrophy type 2: a challenging approach.

Authors:  Giovanni Meola; Fiammetta Biasini; Rea Valaperta; Elena Costa; Rosanna Cardani
Journal:  J Neurol       Date:  2017-05-26       Impact factor: 4.849

Review 6.  Myotonic dystrophy type 2 and related myotonic disorders.

Authors:  Giovanni Meola; Richard T Moxley
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

7.  A Z-DNA sequence reduces slipped-strand structure formation in the myotonic dystrophy type 2 (CCTG) x (CAGG) repeat.

Authors:  Sharon F Edwards; Mario Sirito; Ralf Krahe; Richard R Sinden
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

8.  Myotonic dystrophies 1 and 2: complex diseases with complex mechanisms.

Authors:  Benedikt Schoser; Lubov Timchenko
Journal:  Curr Genomics       Date:  2010-04       Impact factor: 2.236

9.  Spinocerebellar ataxia type 31 is associated with "inserted" penta-nucleotide repeats containing (TGGAA)n.

Authors:  Nozomu Sato; Takeshi Amino; Kazuhiro Kobayashi; Shuichi Asakawa; Taro Ishiguro; Taiji Tsunemi; Makoto Takahashi; Tohru Matsuura; Kevin M Flanigan; Sawa Iwasaki; Fumitoshi Ishino; Yuko Saito; Shigeo Murayama; Mari Yoshida; Yoshio Hashizume; Yuji Takahashi; Shoji Tsuji; Nobuyoshi Shimizu; Tatsushi Toda; Kinya Ishikawa; Hidehiro Mizusawa
Journal:  Am J Hum Genet       Date:  2009-10-29       Impact factor: 11.025

Review 10.  Myotonic dystrophy: RNA pathogenesis comes into focus.

Authors:  Laura P W Ranum; John W Day
Journal:  Am J Hum Genet       Date:  2004-04-02       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.